GPC3 and hepatocellular carcinoma: Wang et al. composed a recombinant immunotoxin from the enzymatic moiety of ExoA, domain III, and HN3 antibody that targets Glypican-3 (GPC3) antigens that are overexpressed in hepatocellular carcinoma (HCC).